日期 | 时间 | 会场 | Session | 角色 | 讲题 |
---|---|---|---|---|---|
2024-09-20 | 16:07-16:15 | 分会场7:江碧厅 |
临床研究会场8 |
讲者 | Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study |